Allegations leveled against CVS Caremark accused the PBM of preferring more expensive versions of insulin in order to boost ...

On July 14, 2026, the Federal Trade Commission (FTC) announced its settlement with Caremark Rx, LLC and Zinc Health Services, LLC (Caremark) ...

Caremark, Optum and Express Scripts artificially drove up the list prices of drugs by creating a system that gave preference ...

CVS Caremark today announced a global settlement with the Federal Trade Commission (FTC) which further advances the company's leadership in delivering greater affordability for prescription drugs. The ...

Settlement aims to drive down patients’ out-of-pocket costs and increase transparency According to FTC, the settlement locks ...

The plaintiffs in a healthcare fiduciary suit argue that just showing a prudent process may not satisfy ERISA's prohibited transaction exemption.

It’s a very good thing for probably several dozen pharmacies throughout the state,” said Rob Frankil, executive director of ...

A new FTC settlement with CVS Caremark could lower prescription costs for some Georgia patients and save consumers billions over the next decade.

The FTC settled a lawsuit against CVS Caremark over allegations that the company artificially inflated the price of insulin and impeded access to the diabetes treatment.

A new CVS Caremark settlement caps insulin costs and sets up a deductible change for TrumpRx purchases. Here's what's in the ...

CVS Caremark reached a global settlement to resolve all outstanding litigation and investigations involving CVS Health -- including its pharmacy benefits management and affiliated pharmacy businesses ...

A rebate-driven formulary model allegedly incentivized higher insulin list prices, affecting three PBMs controlling roughly ...